Astoria Portfolio Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Astoria Portfolio Advisors's LLY Position: Q2 2026 in Review
Astoria Portfolio Advisors increased its Eli Lilly (LLY) stake by 23% in Q2 2026, buying an estimated $425K and bringing the position to 2,257 shares worth $2.71M. The position accounts for 0.46% of the portfolio, ranked #37.
Astoria Portfolio Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Astoria Portfolio Advisors held 2,257 shares of Eli Lilly worth $2.71M as of Q2 2026.
- Astoria Portfolio Advisors bought 416 Eli Lilly shares in Q2 2026, an estimated $425K.
- Eli Lilly made up 0.46% of Astoria Portfolio Advisors's portfolio in Q2 2026, its #37 holding.
- Astoria Portfolio Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Astoria Portfolio Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.